The graph compares how many mvoies were made in 5 different contries between 2007 and 2009. Overall, countries A and B remained principal film producers, outstripping the rest of countries by a wide margin. While changes in almost all the nations were negligible, country B was the exception that recorded the only pronounced rise.

Band 6.0 🚫
In 1994, 15,246 UK residents went abroad for holidays, while 3,155 and 2,689 people had a visit abroad for business purposes.

Band 8.0✔️
In 1994, as many as 15,246 residents from the UK visited a country abroad for holidays, significantly more than those visiting for business purposes (3,155) and, to a larger extent, those visiting friends and relatives (2,689).

The pie graphs compare how much time office workers spent on various tasks in 1980 and 2000 in the US. Over this period, computer use has developed into the main activity, surpassing former most time-consuming task—using phones. Furthermore, while unspecified activities and in-person communication remained unaltered, paper documents, meeting and phones had taken much less time by 2000, in contrast to the remaining activities.

The only two activities that were equally participated in both years were uncategorized tasks and face-to-face communication; their figures collectively accounted for 29% of the total time. Paper documents and phone use, however, recorded decreases in the 20-year span. In 1980, office workers used as much as 30% of their time using phones, a figure that shrank to 17% two decades later, thus marking the sharpest fall. The other marked drop was seen in paperwork: its proportion halved to 10% in 2000.

Patterns for the rest of activities were growing, with that of computers doing so the most. In particular, there was a surge in the usage of computers, as the percentage of time spent on it rose fifteen-fold to a chart high of 30%, a stark contrast to the figure for meeting dwindling roughly three-fold to 6%. The final notable change was the introduction of emailing in 2000, which required the least time (8%) in the year.

✅ stretched as long/far as 250 km
✅ had a length of 250 km
✅ ran 250 km in length
✅ had an 250-km length
✅ was 250 km long
✅ had a 250-km stretch of

The line compares the proportion of people of different ages going to the cinema from 1978 to 2008. Overall, visiting the cinema was much more common in the two youngest age ranges than in the old ones, with the patterns of change being virtually identical across the age groups. In particular, despite a dip in the first half of the timeframe, all the age brackets saw a gradual recovery in the second half.

14-24-year-olds and 25-34-year-olds, while ranking first and second on the list, recorded similar decreases from the initial 90% (an all-time high) and 80%, respectively, to roughly 75% and 60% in 1978. By 1998, both figures had gone up, with the former rebounding to its original point and the latter rising by 10%. Remaining unaltered in the following 5 years, these shares then witnessed a slight drop, albeit of varying levels: cinema-goers aged 14-24 saw a final decline to 80% (10% lower than the 1978 level), while their 25-34-year-old counterparts experienced a less notable to 65% (a 15-percent drop over the timespan).

The other two age classes also showed similar trajectories. In 1978, as many as 60% of adult cinema visitors were recorded, compared to seniors at 50 and above standing at a mere 40%. There was a 20-percent fall in both figures in 1988, which then was followed by a recovery to the initial level in 1998 and a period of stability untill 2003. From that year on, the two percentages followed different trends, as cinema attendance dwindled to 50% among the middle-aged adults. This was in stark contrast to the older cinema attendees, who caught up with the 35-39 age category at the end.

Overall, European and African suppliers remained the principal drug suppliers, in stark contrast to their South American counterparts. While two bigger drug providers, namely Europe and Africa as well as North America, experienced a decline in figure, South America witnessed a dip yet rebounded at the end. Asia, however, was the only drug manufacturer to have seen a steady upward.